首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

2047015

馬人工授精市場－全球產業規模、佔有率、趨勢、機會和預測：按解決方案、馬匹品種、分銷管道、地區和競爭格局分類，2021-2031年

Equine Artificial Insemination Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Solution, By Equine Type, By Distribution Channel, By Region & Competition, 2021-2031F

出版日期: 2026年05月25日 | 出版商:

TechSci Research | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球馬匹人工授精市場預計將從 2025 年的 6.7805 億美元成長到 2031 年的 9.5585 億美元，複合年成長率為 5.89%。

該專業專注於採集、處理和注射種公馬精液，以使母馬無需自然交配即可懷孕。其主要成長要素包括優良的遺傳特性和高效率的疾病管理。這使得人們能夠獲得全球範圍內的優質血統，同時降低生物安全風險。例如，根據世界馬匹育種聯合會（WBFSH）的一份報告，KWPN（荷蘭溫血馬）血統將在2025年獲得12,783分，位居馬場馬術排名榜首，這將顯著提升對先進繁殖服務和冷凍精液的需求。然而，該市場面臨許多挑戰，例如經濟不穩定以及獸醫治療和物流成本的不斷上漲，這些因素可能會降低參與度。在營運成本飆升的現有育種區域，這種趨勢尤其明顯。例如，根據德國馬術聯合會的一份報告，上一個繁殖季的登記配種次數在 2025 年下降到 23,809 次，這主要是由於市場不確定性影響了人工授精的數量。

市場概覽
預測期	2027-2031
市場規模：2025年	6.7805億美元
市場規模：2031年	9.5585億美元
複合年成長率：2026-2031年	5.89%
成長最快的細分市場	精液
最大的市場	北美洲

市場促進因素

全球馬匹人工授精市場的主要驅動力是對優質馬匹遺傳資源日益成長的需求。育種者越來越傾向於獲取精英血統，以最大限度地發揮幼駒的商業性和競技潛力，這需要先進的生殖技術，使成熟種公馬的精液能夠隨時隨地獲取。這顯著提高了幼駒的遺傳品質。頂級遺傳品質帶來的巨大經濟效益在夸特馬等產業尤為明顯，人工授精在這些產業中應用廣泛。 2025年1月，美國夸特馬協會（AQHA）報告稱，頂級種公馬「Favorite Cartel」的後代在2024賽季贏得了約930萬美元的獎金，凸顯了優質遺傳成果的巨大經濟價值，並鼓勵育種者投資於育種服務。同時，馬術比賽和賽馬運動參與度的不斷提高也是一個關鍵促進因素，促使全球育種服務範圍擴大，以滿足國際比賽標準。高水準賽事的日益增多推動了全球競爭激烈、以競技成績為導向的馬匹市場的發展，並促進了相關獸醫護理和育種市場的蓬勃發展。市場繁榮體現在對賽馬的強勁需求上，基蘭賽馬協會（Keeneland Association）報告稱，其2025年9月的周歲馬拍賣會總銷售額創下5.315億美元的紀錄。這反映了市場對競技馬匹的強勁需求，並增強了整個育種供應鏈的活力。同時，產業管治也在加強努力，以確保永續發展。國際馬術聯合會（FEI）在其2024年度報告中承諾向新的馬匹福利基金捐贈100萬瑞士法郎，彰顯了其對競技馬匹永續發展的承諾，而競技馬匹對於該市場至關重要。

市場挑戰

由於經濟波動以及獸醫操作和物流相關的高成本，全球馬匹人工授精市場面臨嚴峻挑戰。這是因為人工授精是一項資本密集流程，需要專業的獸醫服務來進行精液採集、處理和運輸。在經濟不確定時期，這些高昂的營運成本會成為許多育種者的負擔，迫使他們縮減育種計劃，甚至完全放棄先進的繁殖技術。因此，人工授精服務的市場規模和冷凍精液的分銷量直接萎縮。主要運動馬匹組織的最新育種數據顯示，這些經濟壓力的影響顯而易見。例如，根據荷蘭國家馬協會 (KWPN) 的一份報告，註冊幼駒的數量從上一年的約 11,000 匹減少到 2024 年的 10,500 匹。幼駒註冊數量的下降表明育種活動減少，這主要是由於成本上升，因此，由於育種者優先考慮成本控制而不是擴大馬群規模，人工授精的數量也在減少。

市場趨勢

胞漿內單一精子注射（ICSI）技術的日益普及正在從根本上改變著市場格局。 ICSI 最初只是一種特殊的搶救技術，如今已發展成為培育高價值運動馬的主要方法，透過使稀有精液的種公馬和低生育力的母馬能夠繁育出幼駒，從而開闢了一個高階市場。因此，幼駒的商業性價值顯著提升。近期拍賣結果也印證了這項價值導向的轉變。根據 Avantea 公司 2024 年 10 月發布的報告《OPU-ICSI：革新運動馬繁殖的生物技術》，在 2024 年桑格海德優質馬匹競標，透過 OPU-ICSI 受孕的幼駒平均售價超過 5 萬歐元，比傳統人工授精的幼駒溢價超過 20%。同時，性別分選精液技術的商業性化應用也正在加速發展。這主要得益於流式細胞技術技術的進步，該技術提高了選擇效率。這使得育種者能夠根據市場需求，策略性地調整幼駒的性別，例如優先選擇母馬用於未來的繁殖，或為特定的賽馬賽事選擇種公馬，從而最大限度地提高每次妊娠的投資回報率。此方法的實際有效性已在近期的商業應用中得到證實。根據發表於2024年12月《馬獸醫學雜誌》（Journal of Equine Veterinary Science）的報導《馬科動物性別選擇精液的應用》（Use of Sex-Selected Semen in Equines），大規模的現場評估證實，選擇精液的性別鑑定準確率達到了90.3%。這一可靠性水平有效地解決了先前阻礙其在行業內廣泛應用的效率問題。

The global equine artificial insemination market is projected to expand from USD 678.05 million in 2025 to USD 955.85 million by 2031, exhibiting a compound annual growth rate of 5.89%. This specialized sector focuses on collecting, processing, and depositing stallion semen into mares to achieve pregnancy without natural breeding. Key growth catalysts include the drive for superior genetic traits and efficient disease control, enabling global access to elite bloodlines while reducing biosecurity risks; for instance, in 2025, the KWPN studbook's leading position in dressage rankings with 12,783 points, as reported by the World Breeding Federation for Sport Horses, significantly influences the demand for advanced reproductive services and frozen semen. Nevertheless, the market faces significant hurdles from economic instability and the elevated costs of veterinary procedures and logistics, which can decrease participation, particularly in established breeding regions with rising operational expenses, as illustrated by the German Equestrian Federation reporting a decline in registered coverings to 23,809 in 2025 for the preceding breeding season, primarily due to market uncertainty impacting artificial insemination volumes.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 678.05 Million
Market Size 2031	USD 955.85 Million
CAGR 2026-2031	5.89%
Fastest Growing Segment	Semen
Largest Market	North America

Market Driver

A primary driver for the Global Equine Artificial Insemination Market is the escalating demand for superior equine genetics, with breeders increasingly seeking access to elite bloodlines to optimize the commercial and athletic potential of their offspring, requiring advanced reproductive technologies that facilitate the use of semen from proven stallions regardless of their physical location, thereby significantly improving the genetic quality of foals; the substantial financial returns associated with top-tier genetics are evident in industries like the Quarter Horse sector, where artificial insemination is prevalent, with the American Quarter Horse Association reporting in January 2025 that the leading sire Favorite Cartel's progeny earned approximately $9.3 million during the 2024 racing season, highlighting the significant economic value placed on premier genetic output and motivating breeder investment in reproductive services. Concurrently, increased participation in equestrian sports and racing serves as another key catalyst, broadening the scope of reproductive services globally to meet international competitive benchmarks, where the proliferation of high-level competitions intensifies the need for performance-bred horses capable of competing globally, fostering a strong economy that supports related veterinary and breeding markets; this market vigor is demonstrated by the robust demand for racing prospects, with Keeneland Association reporting a record gross of $531.5 million at its September Yearling Sale in September 2025, reflecting a strong desire for performance horses and bolstering the broader reproductive supply chain, while industry governance is also enhancing efforts to ensure sustainable growth, as the Federation Equestre Internationale, in its June 2025 'Annual Report 2024', committed CHF 1 million to a new Equine Welfare Fund, underscoring its dedication to the sustainable development of sport horses vital to this market.

Market Challenge

The global equine artificial insemination market faces significant challenges due to economic volatility and the high costs associated with veterinary procedures and logistics, as artificial insemination is a capital-intensive process requiring specialized veterinary services for semen collection, processing, and transportation; during times of financial uncertainty, these substantial operational expenses can become prohibitive for numerous breeders, leading them to either reduce their breeding programs or entirely forgo advanced reproductive technologies, which directly shrinks the available market for artificial insemination services and frozen semen distribution. The effects of these financial strains are evident in recent breeding data from prominent sport horse organizations; for instance, the KWPN reported a decrease in registered foals to 10,500 in 2024, down from approximately 11,000 in the preceding year, a downward trend in foal registrations that signals a reduction in breeding activities primarily driven by rising costs, which in turn diminishes the volume of artificial insemination procedures as breeders prioritize cost control over herd expansion.

Market Trends

The increasing adoption of Intracytoplasmic Sperm Injection (ICSI) is fundamentally reshaping the market, evolving from a specialized rescue technique to a primary method for breeding high-value sport horses, establishing a premium market segment by enabling breeders to produce foals from stallions with scarce semen or sub-fertile mares, resulting in offspring with considerably higher commercial valuations; this shift towards value is underscored by recent auction figures, with Avantea's October 2024 report, 'OPU-ICSI: The Biotechnology Revolutionizing Sport Horse Breeding', indicating that foals conceived through OPU-ICSI achieved an average price exceeding €50,000 at the 2024 Zangersheide Quality Auction, representing a premium of over 20% compared to those from traditional insemination. Simultaneously, the commercial deployment of sex-sorted semen technology is gaining momentum, driven by enhancements in flow cytometry that improve sorting efficiency, allowing breeders to strategically match foal gender with specific market requirements, such as prioritizing fillies for future breeding stock or colts for particular racing disciplines, thereby maximizing the return on investment per pregnancy; the practical effectiveness of this method has been corroborated in recent commercial uses, as the Journal of Equine Veterinary Science, in its December 2024 article 'The use of sex-sorted semen in horses', reported that large-scale field evaluations confirmed sex accuracy for sorted semen reached 90.3%, a reliability level that effectively addresses previous concerns regarding efficiency that impeded its widespread industry acceptance.

Key Market Players

EquiTech International Ltd.
IVF Bioscience Ltd.
Cryologics Pty Ltd.
Minitube International GmbH
IMV Technologies
Inguran LLC
Genetica & Hormonas S.A.
REPROCELL Equine Solutions
Double Diamond Equine Services
Equine Medical & Surgical Associates, Inc.

Report Scope

In this report, the Global Equine Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Artificial Insemination Market, By Solution

Equipment & Consumables
Semen
Services

Equine Artificial Insemination Market, By Equine Type

Sports/Racing
Recreation
Others

Equine Artificial Insemination Market, By Distribution Channel

Private
Public

Equine Artificial Insemination Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Artificial Insemination Market.

Available Customizations:

Global Equine Artificial Insemination Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Artificial Insemination Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Solution (Equipment & Consumables, Semen, Services)
- 5.2.2. By Equine Type (Sports/Racing, Recreation, Others)
- 5.2.3. By Distribution Channel (Private, Public)
- 5.2.4. By Region
- 5.2.5. By Company (2025)
5.3. Market Map

6. North America Equine Artificial Insemination Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Solution
- 6.2.2. By Equine Type
- 6.2.3. By Distribution Channel
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Equine Artificial Insemination Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Solution
    - 6.3.1.2.2. By Equine Type
    - 6.3.1.2.3. By Distribution Channel
- 6.3.2. Canada Equine Artificial Insemination Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Solution
    - 6.3.2.2.2. By Equine Type
    - 6.3.2.2.3. By Distribution Channel
- 6.3.3. Mexico Equine Artificial Insemination Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Solution
    - 6.3.3.2.2. By Equine Type
    - 6.3.3.2.3. By Distribution Channel

7. Europe Equine Artificial Insemination Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Solution
- 7.2.2. By Equine Type
- 7.2.3. By Distribution Channel
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Equine Artificial Insemination Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Solution
    - 7.3.1.2.2. By Equine Type
    - 7.3.1.2.3. By Distribution Channel
- 7.3.2. France Equine Artificial Insemination Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Solution
    - 7.3.2.2.2. By Equine Type
    - 7.3.2.2.3. By Distribution Channel
- 7.3.3. United Kingdom Equine Artificial Insemination Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Solution
    - 7.3.3.2.2. By Equine Type
    - 7.3.3.2.3. By Distribution Channel
- 7.3.4. Italy Equine Artificial Insemination Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Solution
    - 7.3.4.2.2. By Equine Type
    - 7.3.4.2.3. By Distribution Channel
- 7.3.5. Spain Equine Artificial Insemination Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Solution
    - 7.3.5.2.2. By Equine Type
    - 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Equine Artificial Insemination Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Solution
- 8.2.2. By Equine Type
- 8.2.3. By Distribution Channel
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Equine Artificial Insemination Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Solution
    - 8.3.1.2.2. By Equine Type
    - 8.3.1.2.3. By Distribution Channel
- 8.3.2. India Equine Artificial Insemination Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Solution
    - 8.3.2.2.2. By Equine Type
    - 8.3.2.2.3. By Distribution Channel
- 8.3.3. Japan Equine Artificial Insemination Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Solution
    - 8.3.3.2.2. By Equine Type
    - 8.3.3.2.3. By Distribution Channel
- 8.3.4. South Korea Equine Artificial Insemination Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Solution
    - 8.3.4.2.2. By Equine Type
    - 8.3.4.2.3. By Distribution Channel
- 8.3.5. Australia Equine Artificial Insemination Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Solution
    - 8.3.5.2.2. By Equine Type
    - 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Equine Artificial Insemination Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Solution
- 9.2.2. By Equine Type
- 9.2.3. By Distribution Channel
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Equine Artificial Insemination Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Solution
    - 9.3.1.2.2. By Equine Type
    - 9.3.1.2.3. By Distribution Channel
- 9.3.2. UAE Equine Artificial Insemination Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Solution
    - 9.3.2.2.2. By Equine Type
    - 9.3.2.2.3. By Distribution Channel
- 9.3.3. South Africa Equine Artificial Insemination Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Solution
    - 9.3.3.2.2. By Equine Type
    - 9.3.3.2.3. By Distribution Channel

10. South America Equine Artificial Insemination Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Solution
- 10.2.2. By Equine Type
- 10.2.3. By Distribution Channel
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Equine Artificial Insemination Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Solution
    - 10.3.1.2.2. By Equine Type
    - 10.3.1.2.3. By Distribution Channel
- 10.3.2. Colombia Equine Artificial Insemination Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Solution
    - 10.3.2.2.2. By Equine Type
    - 10.3.2.2.3. By Distribution Channel
- 10.3.3. Argentina Equine Artificial Insemination Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Solution
    - 10.3.3.2.2. By Equine Type
    - 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Equine Artificial Insemination Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. EquiTech International Ltd.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. IVF Bioscience Ltd.
15.3. Cryologics Pty Ltd.
15.4. Minitube International GmbH
15.5. IMV Technologies
15.6. Inguran LLC
15.7. Genetica & Hormonas S.A.
15.8. REPROCELL Equine Solutions
15.9. Double Diamond Equine Services
15.10. Equine Medical & Surgical Associates, Inc.